Lacut K - Search Results

1

Major bleeding risk associated with oral anticoagulant in real clinical practice. A multicentre 3-year period population-based prospective cohort study.

Bouget J, Balusson F, Maignan M, Pavageau L, Roy PM, Lacut K, Scailteux LM, Nowak E, Oger E. Bouget J, et al. Among authors: lacut k. Br J Clin Pharmacol. 2020 Dec;86(12):2519-2529. doi: 10.1111/bcp.14362. Epub 2020 Jun 1. Br J Clin Pharmacol. 2020. PMID: 32415705 Free PMC article.

2

Is APC resistance a risk factor for venous thromboembolism in patients over 70 years?

Oger E, Lacut K, Le Gal G, Van Dreden P, Bressollette L, Scarabin PY, Leroyer C, Mottier D. Oger E, et al. Among authors: lacut k. Thromb Haemost. 2002 Oct;88(4):587-91. Thromb Haemost. 2002. PMID: 12362228

3

High prevalence of asymptomatic deep vein thrombosis on admission in a medical unit among elderly patients.

Oger E, Bressollette L, Nonent M, Lacut K, Guias B, Couturaud F, Leroyer C, Mottier D. Oger E, et al. Among authors: lacut k. Thromb Haemost. 2002 Oct;88(4):592-7. Thromb Haemost. 2002. PMID: 12362229

4

[Deep venous thrombosis: epidemiology, acquired risk factors].

Oger E, Lacut K, Scarabin PY. Oger E, et al. Among authors: lacut k. Ann Cardiol Angeiol (Paris). 2002 Jun;51(3):124-8. doi: 10.1016/s0003-3928(02)00083-5. Ann Cardiol Angeiol (Paris). 2002. PMID: 12471641 Review. French.

5

High plasma concentration of factor VIII coagulant is also a risk factor for venous thromboembolism in the elderly.

Oger E, Lacut K, Van Dreden P, Bressollette L, Abgrall JF, Blouch MT, Scarabin PY, Mottier D. Oger E, et al. Among authors: lacut k. Haematologica. 2003 Apr;88(4):465-9. Haematologica. 2003. PMID: 12681975

6

Differential effects of oral and transdermal estrogen/progesterone regimens on sensitivity to activated protein C among postmenopausal women: a randomized trial.

Oger E, Alhenc-Gelas M, Lacut K, Blouch MT, Roudaut N, Kerlan V, Collet M, Abgrall JF, Aiach M, Scarabin PY, Mottier D; SARAH Investigators. Oger E, et al. Among authors: lacut k. Arterioscler Thromb Vasc Biol. 2003 Sep 1;23(9):1671-6. doi: 10.1161/01.ATV.0000087141.05044.1F. Epub 2003 Jul 17. Arterioscler Thromb Vasc Biol. 2003. PMID: 12869355 Clinical Trial.

7

Differential effects of oral and transdermal postmenopausal estrogen replacement therapies on C-reactive protein.

Lacut K, Oger E, Le Gal G, Blouch MT, Abgrall JF, Kerlan V, Scarabin PY, Mottier D; SARAH Investigators. Lacut K, et al. Thromb Haemost. 2003 Jul;90(1):124-31. Thromb Haemost. 2003. PMID: 12876635 Clinical Trial.

8

Effects of oral and transdermal 17 beta-estradiol combined with progesterone on homocysteine metabolism in postmenopausal women: a randomised placebo-controlled trial.

Lacut K, Oger E, Abalain JH, Moineau MP, Mottier D; SARAH Investigators. Lacut K, et al. Atherosclerosis. 2004 May;174(1):173-80. doi: 10.1016/j.atherosclerosis.2004.01.021. Atherosclerosis. 2004. PMID: 15135267 Clinical Trial.

9

Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital-based case-control study.

Lacut K, Oger E, Le Gal G, Couturaud F, Louis S, Leroyer C, Mottier D. Lacut K, et al. Fundam Clin Pharmacol. 2004 Aug;18(4):477-82. doi: 10.1111/j.1472-8206.2004.00252.x. Fundam Clin Pharmacol. 2004. PMID: 15312155

10

[Hormone therapy and risk for venous thromboembolism in postmenopausal women].

Lacut K, Oger E. Lacut K, et al. Rev Prat. 2005 Feb 28;55(4):389-92. Rev Prat. 2005. PMID: 15828617 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters